Endocrine Society 2017 pediatric obesity guideline: key recommendations

Who it applies to

Children and adolescents being evaluated or treated for overweight or obesity in primary care and specialist pediatric settings.

Key recommendations

• Use BMI percentile for age and sex to screen for overweight and obesity at routine well-child visits.
• In children with obesity, evaluate for underlying causes and obesity-related comorbidities such as dyslipidemia, hypertension, abnormal glucose metabolism, and nonalcoholic fatty liver disease.
• Recommend against routine laboratory testing for endocrine causes of obesity unless history or exam findings (such as short stature or growth deceleration) suggest an underlying endocrine disorder.
• Offer intensive lifestyle modification involving diet, physical activity, behavioral change, and family involvement as the first-line treatment for pediatric obesity.
• Reserve pharmacotherapy for children with obesity who have not responded adequately to lifestyle intervention, generally after a formal trial of structured lifestyle modification.
• Metformin may be considered when a child with obesity has a specific indication such as prediabetes or type 2 diabetes, but the guideline suggests against using metformin specifically for weight loss or to limit weight gain in pediatric obesity, given its modest effect on weight.
• Consider bariatric surgery only in adolescents with severe obesity who have failed lifestyle and medical therapy, particularly when significant comorbidities are present, and only in experienced multidisciplinary centers.
• Avoid the use of weight-loss medications and bariatric surgery in young children, restricting these options mainly to adolescents who meet specific severity criteria.
• Encourage breastfeeding and promote healthy growth patterns in infancy as part of obesity prevention efforts.
• Support population- and family-level prevention strategies, including limiting sugar-sweetened beverage intake and encouraging regular physical activity and adequate sleep.

Practice points for students

• BMI percentile for age and sex, not absolute BMI, is the key screening tool in children.
• Short stature or slowing growth velocity in a child with obesity should prompt evaluation for an endocrine cause rather than assuming simple obesity.
• Lifestyle intervention should be intensive and family-centered before considering drugs or surgery.
• Bariatric surgery is generally restricted to adolescents with severe obesity and significant comorbidities, not younger children.

Condition

Other guidelines on this topic

• Adult Overweight and Obesity Management: Updates From the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice GuidelinesACP2026Official guideline
• Overweight and obesity management (NG246)NICE2026Official guideline
• AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With ObesityAGA2022Summary

Independent educational summary written by the WhiteCoat Pro editorial team with AI assistance and checked by a second AI model. It does not reproduce the guideline text, tables or figures, and it is not affiliated with or endorsed by Endocrine Society. It is not medical advice: always read the original guideline before applying it to patients.